紧急医疗更新:儿科简报解决了无法解释的事件
Brit Long1, Anna M DePompolo2, Michael Gottlieb3
1Department of Emergency Medicine, University of Virginia, Charlottesville, VA, USA.
The American journal of emergency medicine
|January 10, 2026
概括
婴儿的简短解决的不明原因事件 (BRUE) 通常是良性的,但可能导致不必要的评估. 了解当前的证据有助于紧急诊所医生风险分层低风险病例,改善护理和降低医疗保健成本.
科学领域:
- 儿科急救医学 儿科急救医学
- 临床儿科 临床儿科
- 基于证据的医学基于证据的医学.
背景情况:
- 简要解决的不明原因事件 (BRUE) 影响了许多婴儿,通常是良性原因.
- 低风险的BRUE病例经常经历不必要的评估和入院.
- 对于急诊部 (ED) 的临床医生来说,了解当前的BRUE证据至关重要.
研究的目的:
- 评估有关儿科BRUE的基于证据的关键更新.
- 为管理BRUE的紧急诊所医生提供指导.
主要方法:
- 对BRUE当前证据的文献综述.
- 对诊断标准和风险分层方法的分析.
- 专注于急诊室遇到的情况.
主要成果:
- BRUE定义:在1岁以下的婴儿中,突然,短暂 (<1分钟) 的解决事件,呼吸,音调,意识或颜色发生变化.
- BRUE会给护理人员和临床医生带来严重的痛苦.
- 风险分层和共享决策至关重要.
结论:
- 识别低风险的BRUE事件可以最大限度地减少不必要的测试.
- 对非低风险病例进行适当的评估至关重要.
- 了解当前的BRUE文献可以改善儿科患者的紧急护理.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
201
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Pulmonary Embolism I: Introduction
492
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
492
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
298
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
298
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Cardiopulmonary Resuscitation III: AED Use
512
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
512
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185


